High-Dose Chemotherapy with Autologous Hematopoietic Stem-Cell Rescue for Pediatric Brain Tumor Patients: A Single Institution Experience from UCLA

High-Dose Chemotherapy with Autologous Hematopoietic Stem-Cell Rescue for Pediatric Brain Tumor Patients: A Single Institution Experience from UCLA

Background. Dose-dependent response makes certain pediatric brain tumors appropriate targets for high-dose chemotherapy with autologous hematopoietic stem-cell rescue (HDCT-AHSCR). Methods. The clinical outcomes and toxicities were analyzed retrospectively for 18 consecutive patients ≤19 y/o treate...

Full description

Bibliographic Details
Main Authors: Eduard H. Panosyan, Alan K. Ikeda, Vivian Y. Chang, Dan R. Laks, Charles L. Reeb, La Vette Bowles, Joseph L. Lasky, Theodore B. Moore
Format: Article
Language:English
Published: Hindawi Limited 2011-01-01
Series:Journal of Transplantation
Online Access:http://dx.doi.org/10.1155/2011/740673

Internet

http://dx.doi.org/10.1155/2011/740673

Similar Items